Softwr

Healthcare · head to head

OpenMRS vs Woebot Health

OpenMRS logo

OpenMRS

Healthcare

Open source electronic medical record platform for low-resource settings, with no vendor and paid implementers instead

From
Free
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only OpenMRS has a free tier, so it costs nothing to try first.
  • Each has a real cost: OpenMRS there is no vendor and no support contract from OpenMRS itself, so a procurement that requires a named supplier with a service level must instead contract an implementer, and the quality of that implementer determines the outcome more than the software does; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: OpenMRS covers Concept dictionary, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which OpenMRS and Woebot Health actually diverge.

Attributes where OpenMRS and Woebot Health differ
AttributeOpenMRSWoebot Health
Starting priceFreeOn request
Pricing modelOpen source, no licence feequote
Free tierYesNo
PlatformsLinux, Web, WindowsiOS, Android, Web

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in OpenMRS

  • Concept dictionary
  • Modular architecture
  • Modern front end
  • FHIR support
  • Offline tolerance
  • Patient matching and registration
  • Distributions

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

OpenMRS

  • A ministry of health standardising HIV treatment records across hundreds of facilities where per-patient licensing would be unaffordablenot Woebot Health
  • A hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirementsnot Woebot Health
  • An NGO running a tuberculosis programme that must report into DHIS2 and needs the clinical record beneath it to be modifiablenot Woebot Health
  • A health system that wants to own its clinical data model outright rather than depend on a vendor to extend itnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot OpenMRS
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot OpenMRS
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot OpenMRS
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot OpenMRS

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

OpenMRS

  • There is no vendor and no support contract from OpenMRS itself, so a procurement that requires a named supplier with a service level must instead contract an implementer, and the quality of that implementer determines the outcome more than the software does
  • It is a framework rather than a ready product, so a deployment requires clinical content, form design, concept dictionary work and integration before a single patient is registered, and that work is months of skilled effort
  • Funding comes largely from donor programmes, which makes the pace of core development dependent on grant cycles rather than on a commercial roadmap, and priorities can shift when a funder does
  • Distribution choice, core OpenMRS against Bahmni against Ozone, locks in a different set of components and a different implementer pool, and migrating between distributions later is close to a fresh implementation
  • The people cost never goes away: a national deployment needs permanent internal informatics capacity or a permanent support contract, and organisations that budget only the zero licence fee run out of money at the point the system becomes clinically critical

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

OpenMRS

Free
  • OpenMRSFree
    • Openly licensed, no licence fee and no seat limits
    • Community support through forums and the OpenMRS Talk platform
    • No support contract available from OpenMRS itself

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose OpenMRS if

  • You need concept dictionary.
  • You want to start without paying.
  • You work on Linux, Web, Windows.
  • You also want modular architecture.
OpenMRS review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is OpenMRS or Woebot Health better?
Neither clearly leads. OpenMRS starts at Free and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, OpenMRS or Woebot Health?
OpenMRS has a free tier; the other does not. Paid plans start at Free for OpenMRS and On request for Woebot Health.
Does OpenMRS or Woebot Health run on more platforms?
OpenMRS runs on Linux, Web, Windows. Woebot Health runs on iOS, Android, Web.
Can I use OpenMRS for free?
Yes. OpenMRS has a free tier, so you can try it without paying. Woebot Health starts at On request.
What is OpenMRS best used for?
OpenMRS is most often used for a ministry of health standardising hiv treatment records across hundreds of facilities where per-patient licensing would be unaffordable, a hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirements, an ngo running a tuberculosis programme that must report into dhis2 and needs the clinical record beneath it to be modifiable, a health system that wants to own its clinical data model outright rather than depend on a vendor to extend it. Of those, a ministry of health standardising hiv treatment records across hundreds of facilities where per-patient licensing would be unaffordable and a hospital network in a country where no commercial vendor supports the local language, clinical forms or reporting requirements are not what Woebot Health is typically brought in for.
What can OpenMRS do that Woebot Health cannot?
OpenMRS covers Concept dictionary, Modular architecture, Modern front end, FHIR support. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

OpenMRS: Who supports OpenMRS if it breaks?

Not OpenMRS itself. Support is bought from implementers such as Mekom Solutions, which offers long-term production service level agreements for OpenMRS, Bahmni and Ozone deployments, or from regional partners.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

OpenMRS: Is it really free?

The software has no licence fee. Hosting, configuration, clinical content, integration and support are the real cost, and they are ongoing.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

OpenMRS: What is the difference between OpenMRS, Bahmni and Ozone?

OpenMRS is the core platform. Bahmni and Ozone are distributions that package it with billing, laboratory and inventory components. Choosing a distribution constrains your implementer options.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

OpenMRS: Does it support FHIR?

Yes. FHIR support is the standard route for integrating laboratory, pharmacy and national reporting systems.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on OpenMRS

More on Woebot Health

Keep looking

Other head to heads